High sensitive immunophenotyping and DNA ploidy techniques for minimal residual disease investigation in multiple myeloma.

被引:0
|
作者
Almeida, J
Orfao, A
Ocqueteau, M
Mateo, G
Corral, M
Caballero, D
Blade, J
San Miguel, JF
机构
[1] Univ Hosp, Hematol Serv, Dept Med, Univ Salamanca, Salamanca, Spain
[2] Hosp Clin, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
401
引用
收藏
页码:98A / 98A
页数:1
相关论文
共 50 条
  • [31] Molecular detection of minimal residual disease in multiple myeloma
    Bai, Yinlei
    Orfao, Alberto
    Sang Chim, Chor
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 11 - 26
  • [32] Minimal residual disease in multiple myeloma: current status
    Hong Ding
    Juan Xu
    Zhimei Lin
    Jingcao Huang
    Fangfang Wang
    Yan Yang
    Yushan Cui
    Hongmei Luo
    Yuhan Gao
    Xinyu Zhai
    Weicui Pang
    Li Zhang
    Yuhuan Zheng
    Biomarker Research, 9
  • [33] Imaging Measurable (Minimal) Residual Disease in Multiple Myeloma
    Bhutani M.
    Usmani S.Z.
    Taneja A.
    Landgren O.
    Current Radiology Reports, 4 (12)
  • [34] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    HAEMATOLOGICA, 2024, 109 (07) : 2049 - 2059
  • [35] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2049 - 2059
  • [36] Recommendations for quantitation of minimal residual disease in multiple myeloma
    Rasmussen, T
    Johnsen, HE
    BONE MARROW TRANSPLANTATION, 2002, 29 : S128 - S128
  • [37] Minimal residual disease diagnostics in patients with multiple myeloma
    Huhn, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 128 - 128
  • [38] Drug resistance and minimal residual disease in multiple myeloma
    Gozzetti, Alessandro
    Ciofini, Sara
    Sicuranza, Anna
    Pacelli, Paola
    Raspadori, Donatella
    Cencini, Emanuele
    Tocci, Dania
    Bocchia, Monica
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 171 - 183
  • [39] Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients
    Kubiczkova-Besse, Lenka
    Drandi, Daniela
    Sedlarikova, Lenka
    Oliva, Stefania
    Gambella, Manuela
    Omede, Paola
    Adam, Zdenek
    Pour, Ludek
    Sevcikova, Sabina
    Boccadoro, Mario
    Palumbo, Antonio
    Hajek, Roman
    BLOOD, 2014, 124 (21)
  • [40] Qualitative and quantitative molecular follow up of minimal residual disease after non myeloablative allografting for multiple myeloma.
    Bruno, B
    Ladetto, M
    Astolfi, M
    Veneziano, L
    Cimolin, L
    Galletto, E
    Pagliano, G
    Rotta, M
    Mordini, N
    Giaccone, L
    Omedè, P
    Battaglio, S
    Storb, R
    Boccadoro, M
    BLOOD, 2004, 104 (11) : 366B - 366B